Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial

Janusz Lipiecki1, Tomasz Siminiak2, Horst Sievert3

  • 1Centre de Cardiologie Interventionnelle, Pôle Santé République Clermont-Ferrand , France.

Open Heart
|August 6, 2016
PubMed

Insights

A modified Carillon device effectively treats functional mitral regurgitation (FMR) in heart failure patients. This percutaneous therapy improved patient outcomes and resolved previous device fracture issues, paving the way for further trials.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Research

Background:

  • Functional mitral regurgitation (FMR) worsens outcomes in congestive heart failure (CHF) and cardiomyopathy patients.
  • Percutaneous coronary sinus-based therapies aim to reduce FMR.

Purpose of the Study:

  • Evaluate the safety and efficacy of a modified Carillon device for FMR treatment.
  • Assess the modified device's performance in patients with cardiomyopathy and FMR.

Main Methods:

  • 36 patients with CHF, reduced ejection fraction (<40%), and moderate-to-severe FMR received the Carillon device implant.
  • The study monitored adverse events, FMR severity, functional class, and 6-minute walk tests.

Main Results:

  • One non-device-related death occurred within 30 days post-implant.
  • Significant reductions in FMR and improvements in functional class and walk tests were observed.
  • Crucially, the issue of device anchor fractures seen in prior studies was not observed.

Conclusions:

  • The modified Carillon device shows promise for treating FMR, improving clinical and echocardiographic parameters.
  • This revised device successfully addressed the prior anchor fracture problem.
  • The modified device is slated for use in an upcoming blinded, randomized trial for symptomatic FMR patients.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
420
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
500
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
387
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
718
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
972
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
478